Dr Steven Ferris, PHARMD | |
908 Walnut Ln, Crown Point, IN 46307-3724 | |
(219) 242-0269 | |
Not Available |
Full Name | Dr Steven Ferris |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 908 Walnut Ln, Crown Point, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295370732 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 26027183A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Steven Ferris, PHARMD 908 Walnut Ln, Crown Point, IN 46307-3724 Ph: (219) 242-0269 | Dr Steven Ferris, PHARMD 908 Walnut Ln, Crown Point, IN 46307-3724 Ph: (219) 242-0269 |
News Archive
A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has been awarded a five-year, $5.7 million National Cancer Institute grant to evaluate long-term health outcomes for cancer patients who receive platinum-based chemotherapies.
NSM Insurance Group announced the establishment of a specialty Behavioral Health, Social Services Unit due to NSM's remarkable growth in this niche over the last 5 years. Bill McKernan, NSM President commented, "It made perfect sense that our Retail clients benefit from the vast expertise NSM has in this space so we created a team comprised of NSM's most experienced Behavioral Health and Social Service Insurance Professionals."
Pandemics caused by novel infectious agents like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Zika, or Ebola virus seriously impact human health and lives while also overwhelming health care systems all over the world. Early detection and diagnosis allow isolation of the infected patients and contact tracing, which can mitigate the spread of the virus and save lives, especially when a significant number of the patients are asymptomatic.
The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.
A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which accounts for 85 percent of all lung cancer cases. They believe that the breakthrough discovery could pave the way for the development of new treatments for a majority of lung cancer patients.
› Verified 4 days ago
Simon Frey, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1003 N Main St, Crown Point, IN 46307 Phone: 219-663-6669 Fax: 219-663-5987 | |
Dr. James Sluis, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Adam Benjamin Jr. Outpatient Clinic, 9300 South Broadway, Crown Point, IN 46307 Phone: 219-662-5090 | |
Kitte Schwimmer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10920 Randolph St, Crown Point, IN 46307 Phone: 219-661-8117 | |
Magdaline Mouratides, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E State Road 231, Crown Point, IN 46307 Phone: 219-662-8854 | |
Mr. James Denton, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 S. Court Street, Crown Point, IN 46307 Phone: 219-663-0336 Fax: 219-663-8647 | |
Trusharkumar Parekh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9150 E 109th Ave, Suite B1, Crown Point, IN 46307 Phone: 219-488-1461 Fax: 219-488-1462 | |
Mr. Andrew J Kasianchuk, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 651 Harvest Ct, Crown Point, IN 46307 Phone: 219-662-1695 |